Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-02-10 @ 3:25 AM
Study NCT ID:
NCT05137795
Status:
WITHDRAWN
Last Update Posted:
2023-02-03
First Post:
2021-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
Sponsor:
APR Applied Pharma Research s.a.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Zyesami_003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None